| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-11 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-11 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.25 | 6e-06 |